158 related articles for article (PubMed ID: 23312367)
1. Asthma therapy in pediatric patients: a systematic review of treatment with montelukast versus inhaled corticosteroids.
Massingham K; Fox S; Smaldone A
J Pediatr Health Care; 2014; 28(1):51-62. PubMed ID: 23312367
[TBL] [Abstract][Full Text] [Related]
2. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review.
Castro-Rodriguez JA; Rodriguez-Martinez CE; Ducharme FM
Pediatr Pulmonol; 2018 Dec; 53(12):1670-1677. PubMed ID: 30394700
[TBL] [Abstract][Full Text] [Related]
3. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review.
Joos S; Miksch A; Szecsenyi J; Wieseler B; Grouven U; Kaiser T; Schneider A
Thorax; 2008 May; 63(5):453-62. PubMed ID: 18443162
[TBL] [Abstract][Full Text] [Related]
4. Do children with stable asthma benefit from addition of montelukast to inhaled corticosteroids: randomized, placebo controlled trial.
Stelmach I; Ożarek-Hanc A; Zaczeniuk M; Stelmach W; Smejda K; Majak P; Jerzynska J; Anna J
Pulm Pharmacol Ther; 2015 Apr; 31():42-8. PubMed ID: 25640020
[TBL] [Abstract][Full Text] [Related]
5. Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy.
Allen-Ramey FC; Bukstein D; Luskin A; Sajjan SG; Markson LE
J Manag Care Pharm; 2006 May; 12(4):310-21. PubMed ID: 16792437
[TBL] [Abstract][Full Text] [Related]
6. Clinical effectiveness of inhaled corticosteroids versus montelukast in children with asthma: prescription patterns and patient adherence as key factors.
Ducharme FM; Noya FJ; Allen-Ramey FC; Maiese EM; Gingras J; Blais L
Curr Med Res Opin; 2012 Jan; 28(1):111-9. PubMed ID: 22077107
[TBL] [Abstract][Full Text] [Related]
7. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
8. [Montelukast in the treatment of mild to moderate persistent asthma].
Bellecoste V; Devouassoux G; Pacheco Y
Rev Mal Respir; 2011 Jun; 28(6):706-29. PubMed ID: 21742233
[TBL] [Abstract][Full Text] [Related]
9. Montelukast versus inhaled corticosteroids as monotherapy for prevention of asthma: which one is best?
Miceli Sopo S; Onesimo R; Radzik D; Scala G; Cardinale F
Allergol Immunopathol (Madr); 2009; 37(1):26-30. PubMed ID: 19268058
[No Abstract] [Full Text] [Related]
10. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?
Jartti T
Eur J Pediatr; 2008 Jul; 167(7):731-6. PubMed ID: 18214538
[TBL] [Abstract][Full Text] [Related]
12. The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma.
Davies GM; Dasbach EJ; Santanello NC; Knorr BA; Bratton DL
Clin Ther; 2004 Nov; 26(11):1895-904. PubMed ID: 15639701
[TBL] [Abstract][Full Text] [Related]
13. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 years with mild persistent asthma.
Szefler SJ; Carlsson LG; Uryniak T; Baker JW
J Allergy Clin Immunol Pract; 2013 Jan; 1(1):58-64. PubMed ID: 24229823
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of step-down therapy from an inhaled steroid to montelukast in childhood asthma.
Ciółkowski J; Mazurek H; Stasiowska B
Allergol Immunopathol (Madr); 2014; 42(4):282-8. PubMed ID: 23684855
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
16. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
Phipatanakul W; Greene C; Downes SJ; Cronin B; Eller TJ; Schneider LC; Irani AM
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory markers as exacerbation risk factors after asthma therapy switch from inhaled steroids to montelukast.
Ciółkowski J; Mazurek H; Hydzik P; Stasiowska B
Pulm Pharmacol Ther; 2016 Aug; 39():7-13. PubMed ID: 27234706
[TBL] [Abstract][Full Text] [Related]
18. The role of inhaled corticosteroids and montelukast in children with mild-moderate asthma: results of a systematic review with meta-analysis.
Castro-Rodriguez JA; Rodrigo GJ
Arch Dis Child; 2010 May; 95(5):365-70. PubMed ID: 19946008
[TBL] [Abstract][Full Text] [Related]
19. Adherence to asthma controller medication regimens.
Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
[TBL] [Abstract][Full Text] [Related]
20. Montelukast: data from clinical trials in the management of asthma.
Blake KV
Ann Pharmacother; 1999 Dec; 33(12):1299-314. PubMed ID: 10630831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]